Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.

Herman LC, Chen L, Garnett A, Feldman LE, Smith B, Weichselbaum RR, Spiotto MT.

Oral Oncol. 2014 Jan;50(1):52-8. doi: 10.1016/j.oraloncology.2013.08.007. Epub 2013 Sep 19.

PMID:
24055193
2.

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.

Lorch JH, Goloubeva O, Haddad RI, Cullen K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE, Posner MR; TAX 324 Study Group.

Lancet Oncol. 2011 Feb;12(2):153-9. doi: 10.1016/S1470-2045(10)70279-5. Epub 2011 Jan 11.

3.

The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.

Teo M, Karakaya E, Young CA, Dyker KE, Coyle C, Sen M, Prestwich RJ.

Clin Oncol (R Coll Radiol). 2013 Nov;25(11):647-53. doi: 10.1016/j.clon.2013.07.007. Epub 2013 Aug 13.

PMID:
23948462
4.

Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck.

Schell A, Ley J, Wu N, Trinkaus K, Wildes TM, Michel L, Thorstad W, Gay H, Lewis J, Rich J, Diaz J, Paniello RC, Nussenbaum B, Adkins DR.

Cancer Med. 2015 Apr;4(4):481-9. doi: 10.1002/cam4.382. Epub 2015 Jan 26.

5.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.

6.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1695-704.

7.

Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.

Schultz JD, Bran G, Anders C, Sadick H, Faber A, Hörmann K, Sauter A.

Oncol Rep. 2010 Nov;24(5):1213-6.

PMID:
20878112
8.

Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.

Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):481-7.

PMID:
15145166
10.

Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.

Cho H, Nishiike S, Yamamoto Y, Takenaka Y, Nakahara S, Yasui T, Hanamoto A, Inohara H.

Auris Nasus Larynx. 2015 Oct;42(5):396-400. doi: 10.1016/j.anl.2015.02.009. Epub 2015 Feb 23.

PMID:
25721854
12.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.

Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27.

PMID:
21620580
13.

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.

Oral Oncol. 2006 Aug;42(7):675-84. Epub 2006 May 30.

PMID:
16731029
14.

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M.

Cancer. 2003 Jan 15;97(2):412-8.

15.

Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.

Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, Machida N, Haraguchi Y, Ogawa H, Nishimura T, Nakagawa M, Fuke T, Iida Y, Kamijo T, Onitsuka T, Boku N, Yasui H, Yokota T.

Int J Clin Oncol. 2015 Jun;20(3):455-62. doi: 10.1007/s10147-014-0749-4. Epub 2014 Sep 25.

PMID:
25248339
16.

Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC).

Shapiro LQ, Sherman EJ, Riaz N, Setton J, Koutcher L, Zhang Z, Shi W, Fury MG, Wolden SL, Pfister DG, Morris L, Lee N.

Oral Oncol. 2014 Oct;50(10):947-55. doi: 10.1016/j.oraloncology.2014.07.001. Epub 2014 Aug 11.

PMID:
25132089
17.

Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.

Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e813-8. doi: 10.1016/j.ijrobp.2010.12.005. Epub 2011 Feb 6.

PMID:
21300455
18.

Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.

Ko EC, Genden EM, Misiukiewicz K, Som PM, Kostakoglu L, Chen CT, Packer S, Kao J.

Oncol Rep. 2012 Feb;27(2):467-74. doi: 10.3892/or.2011.1512. Epub 2011 Oct 21.

PMID:
22020564
19.

Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

Paccagnella A, Mastromauro C, D'Amanzo P, Ghi MG.

Oncologist. 2010;15 Suppl 3:8-12. doi: 10.1634/theoncologist.2010-S3-08.

20.

Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.

Haddad R, Tishler R, Wirth L, Norris CM, Goguen L, Sullivan C, O'Donnell L, Li Y, Posner M.

Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):678-81.

PMID:
16785415
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk